Clinical Trial Update: A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health [Phase 1]

View source ↗

Summary

A Phase 1 randomized, observer-blind, placebo-controlled, dose-escalation trial to evaluate the safety and immunogenicity of the rVSVΔG-MARV-GP vaccine in healt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marburg Virus Disease

Drugs mentioned

• rVSVΔG-MARV-GP vaccine

Snippet

Sponsor: International AIDS Vaccine Initiative | Conditions: Marburg Virus Disease | Phase 1 | Status: RECRUITING